NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial.
Marianna AdamoMatteo PagnesiAlexandre MebazaaBeth DavisonChristopher EdwardsDaniela TomasoniMattia ArrigoMarianela BarrosJan BiegusJelena CelutkieneKamilė Čerlinskaitė-BajorėOvidiu ChioncelAlain Cohen-SolalAlbertino DamascenoRafael DiazGerasimos S FilippatosEtienne GayatAntoine KimmounCarolyn S P LamMaria NovosadovaPeter S PangPiotr PonikowskiHadiza SaiduKaren SliwaKoji TakagiJozine M Ter MaatenCarolyn S P LamGad CotterMarco MetraPublished in: European heart journal (2023)
Among patients with acute HF enrolled in STRONG-HF, HIC reduced 180-day HF readmission or death regardless of baseline NT-proBNP. GRMT up-titration early post-discharge utilizing increased NT-proBNP as guidance to increase diuretic therapy and reduce the GRMT up-titration rate resulted in the same 180-day outcomes regardless of early post-discharge NT-proBNP change.